Market open
Charles River/$CRL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Charles River
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Ticker
$CRL
Sector
Trading on
NYSE
Industry
Life Sciences Tools & Services
Headquarters
Employees
19,400
Website
Charles River Metrics
BasicAdvanced
$5.2B
529.60
$0.20
1.37
-
Price and volume
Market cap
$5.2B
Beta
1.37
52-week high
$254.15
52-week low
$91.86
Average daily volume
1.9M
Financial strength
Current ratio
1.411
Quick ratio
0.921
Long term debt to equity
77.649
Total debt to equity
77.649
Interest coverage (TTM)
3.50%
Management effectiveness
Return on assets (TTM)
3.52%
Return on equity (TTM)
0.71%
Valuation
Price to earnings (TTM)
529.6
Price to revenue (TTM)
1.344
Price to book
1.56
Price to tangible book (TTM)
-49.92
Price to free cash flow (TTM)
10.849
Growth
Revenue change (TTM)
-1.92%
Earnings per share change (TTM)
-97.83%
3-year revenue growth (CAGR)
4.59%
3-year earnings per share growth (CAGR)
-70.26%
What the Analysts think about Charles River
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Charles River stock.
Charles River Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Charles River Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Charles River News
AllArticlesVideos
The 2 Worst Performing S&P 500 Stocks YTD: Buy, Sell, or Avoid?
MarketBeat·3 hours ago
Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call
Business Wire·19 hours ago
FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Charles River stock?
Charles River (CRL) has a market cap of $5.2B as of April 16, 2025.
What is the P/E ratio for Charles River stock?
The price to earnings (P/E) ratio for Charles River (CRL) stock is 529.6 as of April 16, 2025.
Does Charles River stock pay dividends?
No, Charles River (CRL) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next Charles River dividend payment date?
Charles River (CRL) stock does not pay dividends to its shareholders.
What is the beta indicator for Charles River?
Charles River (CRL) has a beta rating of 1.37. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.